Veeco Instruments (VECO) — 2026Q2 FY2026 Earnings Call Analysis

Revenue Raised, EPS Cut, China Risk Doubled

They raised the revenue guide $25M, lowered the EPS guide, and 25% of revenue sits in a jurisdiction blocking their merger.

Thesis: Demand looks real: production tool of record at a Tier 1 HBM maker, all three Tier 1 logic customers engaged on NSA, $200M in Advanced Packaging orders, and $51M OCF against $22M net income. The execution is clean. The problem is that 25% of revenue is China, rising sequentially, while the Axcelis merger waits on China antitrust approval. That is a binary you cannot size. The $200M order ships in 2027 and inflates backlog optics today without contributing revenue, and inventory built $10M while nobody confirmed cancellability.

Verdict: AVOID — Conviction: MEDIUM

Catalyst: Q3 gross margin landing in the 41-42% range despite the 75bps investment drag would force a re-rate of the 2027 margin trajectory. China antitrust clearance for Axcelis would remove the binary overhang.

Key Risk: China at 25% of revenue with Axcelis merger pending China antitrust. A denial severs both the deal and a quarter of the top line simultaneously.

The Tell: Miller volunteered that customers are sharing 'long-range forecasts out beyond 2027, some long-range forecasts that they wouldn't normally be sharing.' Unprompted over-sharing of customer forecast behavior is either genuine conviction or a tell that they need the market to believe 2027 to justify the capacity spend.

Detected Patterns

Say/Do Gap: Revenue guide raised $25M, non-GAAP EPS guide lowered. CFO attributes to $10M incremental OpEx and 75bps gross margin compression from capacity investments. The street caught the contradiction on the first question.
Capital Conviction: Management more than doubling Advanced Packaging and Silicon Photonics capacity ahead of 2027 revenue, backed by $10M OpEx spend and specific capacity plans through internal production and Southeast Asia contract manufacturers.
Backlog Fortress: $200M Advanced Packaging orders secured this quarter for 2027 delivery, plus data storage booked well into 2027 and 'a significant portion' of 2027 revenue already in backlog per CFO.
Export Control Revenue Loss: China revenue is 25% of total and rose sequentially. Axcelis merger lacks China antitrust approval. A regulatory denial severs both the deal and a quarter of the top line.
Inventory Divergence: Inventory rose $10M to $292M while customer deposits rose $45M to $114M. Tool production may be outrunning deliveries. Fine until orders push. Nobody asked if the $200M order is cancellable.
AI Label Without Substance: SAM projections of $1.3B annealing, $700M silicon photonics, $500M IBD, and $2B laser manufacturing by 2030 are aspirational on an $800M revenue base today. The 2027 story rests on evaluation-stage tools.
Unsustainable Trend Confidence: CEO language of 'exceptionally strong,' 'unique level of visibility,' and 'position of strength' with zero hedging in prepared remarks. Confidence is elevated while spending ahead of a 2027 ramp that has not shipped.

Friction Level: MODERATE_FRICTION — Bull reads the $10M OpEx and 75bps GM drag as Capital Conviction for confirmed 2027 demand. Bear reads it as Capacity Ceiling inverted: doubling output before shipments confirm the ramp. Same facts, opposite implications.

Report not found

The report data is no longer available. Please return to the archive.

Revenue Raised, EPS Cut, China Risk Doubled | Silicon Signal